Laufer L R, Gambone J C, Chaudhuri G, Pardridge W M, Judd H L
J Clin Endocrinol Metab. 1983 Jun;56(6):1282-7. doi: 10.1210/jcem-56-6-1282.
To determine the effect of such factors as capillary membrane permeability, plasma protein binding, and capillary transit time on the availability of sex steroids to the uterus, the unidirectional influxes of 3H-labeled steroids from the circulation into the uterus were measured in vivo in anesthetized rats using a tissue-sampling, single injection technique. When dihydrotestosterone (DHT), estradiol (E2), and progesterone (P) were injected with Ringer's solution, the tissue extraction was in excess of 80%; hence, membrane permeability did not play a limiting role. With the more polar steroids, corticosterone and cortisol, uterine extraction was less than 40%. Significant inhibition of tissue extraction of DHT and E2, but not P, occurred with the addition of 4% albumin to the injection solution. Human sera containing increasing concentrations of sex hormone-binding globulin demonstrated inhibition of extraction of DHT and E2. Human sera also inhibited P extraction, presumably secondary to the presence of cortisol-binding globulin and orosomucoid. Large concentrations of unlabeled DHT, E2, and P in the injection solutions did not result in competitive inhibition of labeled steroid extraction. Thus, there is no evidence for a carrier mechanism mediating steroid transport into the uterus. When tissue extraction of E2 from Ringer's solution was compared in liver, brain, and uterus, no difference of tissue permeability could be found. Liver consistently had higher tissue E2 extraction than brain or uterus in the presence of human sera. The results are compatible with the influx of albumin-bound E2 into all three tissues and the influx of sex hormone-binding globulin-bound E2 into the liver.
为了确定诸如毛细血管膜通透性、血浆蛋白结合以及毛细血管转运时间等因素对子宫中性甾体可用性的影响,采用组织采样单次注射技术,在麻醉大鼠体内测量了从循环系统到子宫的³H标记甾体的单向流入量。当用林格氏液注射二氢睾酮(DHT)、雌二醇(E2)和孕酮(P)时,组织摄取率超过80%;因此,膜通透性并未起到限制作用。对于极性更强的甾体皮质酮和皮质醇,子宫摄取率低于40%。向注射溶液中添加4%白蛋白后,DHT和E2的组织摄取受到显著抑制,但P不受影响。含有浓度不断增加的性激素结合球蛋白的人血清显示出对DHT和E2摄取的抑制作用。人血清也抑制P的摄取,推测这是由于存在皮质醇结合球蛋白和类粘蛋白所致。注射溶液中大量未标记的DHT、E2和P并未导致对标记甾体摄取的竞争性抑制。因此,没有证据表明存在介导甾体转运至子宫的载体机制。当比较从林格氏液中摄取E2在肝脏、脑和子宫中的情况时,未发现组织通透性存在差异。在人血清存在的情况下,肝脏的组织E2摄取始终高于脑或子宫。这些结果与白蛋白结合的E2流入所有这三种组织以及性激素结合球蛋白结合的E2流入肝脏的情况相符。